Andon Health's Wholly-Owned Subsidiary Invests 750 Million Yuan Indirectly in DeepSeek

Corporate Action
โดย 证券时报·Read original
Summary · why it matters

Andon Health disclosed that its wholly-owned subsidiary, Andon Hong Kong, indirectly invested in Hangzhou DeepSeek Artificial Intelligence Basic Technology Research Co., Ltd. through Tianjin Shixiang Investment Partnership, with an investment amount of 750 million yuan. The paid-in capital contribution has been completed, and the indirect shareholding ratio after look-through is approximately 0.21%. The company stated that the shareholding ratio is very low, it does not participate in the target company's operations and cannot exert control over it, and its right to know and influence over the target company's actual operating conditions, financial data, major decisions, and potential risk matters is limited. The above investment features a long payback period and low liquidity, and objectively carries the risk of not being able to exit in a timely and effective manner. The company's recent fundamentals have not undergone significant changes, but the stock price has experienced substantial fluctuations due to factors such as market sentiment and concept speculation, and there is a risk of future stock price volatility and decline.

Impact on stocks 1

Others▲ · 1 stocks
Andon Health Co Ltd
002432
± MixedCapitalrelevance

Andon Health invested 750M yuan in DeepSeek via subsidiary, but stake is tiny (0.21%), no control, and investment is illiquid; stock price volatility due to concept speculation.

Off-coverage companies 2

DeepSeekPrivate▲ Positive
Capitalrelevance

DeepSeek received a 750M yuan investment from Andon Health, though the article focuses on Andon's disclosure.

天津拾象投资合伙企业（有限合伙）Private▲ Positive
Capitalrelevance

Tianjin Shixiang Investment Partnership is the vehicle through which the investment was made, receiving capital from Andon Hong Kong.

© 2026 MarketDXNews